169 related articles for article (PubMed ID: 16182466)
1. Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors.
Hasegawa A; Mizoe JE; Mizota A; Tsujii H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):396-401. PubMed ID: 16182466
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.
Demizu Y; Murakami M; Miyawaki D; Niwa Y; Akagi T; Sasaki R; Terashima K; Suga D; Kamae I; Hishikawa Y
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1487-92. PubMed ID: 19345516
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
[TBL] [Abstract][Full Text] [Related]
4. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.
Yanagi T; Mizoe JE; Hasegawa A; Takagi R; Bessho H; Onda T; Kamada T; Okamoto Y; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):15-20. PubMed ID: 19046826
[TBL] [Abstract][Full Text] [Related]
5. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
[TBL] [Abstract][Full Text] [Related]
6. The phase I/II clinical study of carbon ion therapy for cancer of the uterine cervix.
Nakano T; Suzuki M; Abe A; Suzuki Y; Morita S; Mizoe J; Sato S; Miyamoto T; Kamada T; Kato H; Tsujii H
Cancer J Sci Am; 1999; 5(6):362-9. PubMed ID: 10606478
[TBL] [Abstract][Full Text] [Related]
7. Brain injury after proton therapy or carbon ion therapy for head-and-neck cancer and skull base tumors.
Miyawaki D; Murakami M; Demizu Y; Sasaki R; Niwa Y; Terashima K; Nishimura H; Hishikawa Y; Sugimura K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):378-84. PubMed ID: 19735866
[TBL] [Abstract][Full Text] [Related]
8. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.
Arvold ND; Lessell S; Bussiere M; Beaudette K; Rizzo JF; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1166-72. PubMed ID: 19406585
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas.
Schulz-Ertner D; Karger CP; Feuerhake A; Nikoghosyan A; Combs SE; Jäkel O; Edler L; Scholz M; Debus J
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):449-57. PubMed ID: 17363188
[TBL] [Abstract][Full Text] [Related]
10. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy.
Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE
Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365
[TBL] [Abstract][Full Text] [Related]
11. Carbon ion radiotherapy for unresectable sacral chordomas.
Imai R; Kamada T; Tsuji H; Yanagi T; Baba M; Miyamoto T; Kato S; Kandatsu S; Mizoe JE; Tsujii H; Tatezaki S;
Clin Cancer Res; 2004 Sep; 10(17):5741-6. PubMed ID: 15355901
[TBL] [Abstract][Full Text] [Related]
12. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.
Nomiya T; Tsuji H; Hirasawa N; Kato H; Kamada T; Mizoe J; Kishi H; Kamura K; Wada H; Nemoto K; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):828-33. PubMed ID: 18374507
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
14. Standard-fractionated radiotherapy for optic nerve sheath meningioma: visual outcome is predicted by mean eye dose.
Abouaf L; Girard N; Lefort T; D'hombres A; Tilikete C; Vighetto A; Mornex F
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1268-77. PubMed ID: 21640493
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis.
Hirasawa N; Tsuji H; Ishikawa H; Koyama-Ito H; Kamada T; Mizoe JE; Ito Y; Naganawa S; Ohnishi Y; Tsujii H
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):538-43. PubMed ID: 17141971
[TBL] [Abstract][Full Text] [Related]
16. Results of carbon ion radiotherapy for head and neck cancer.
Mizoe JE; Hasegawa A; Jingu K; Takagi R; Bessyo H; Morikawa T; Tonoki M; Tsuji H; Kamada T; Tsujii H; Okamoto Y;
Radiother Oncol; 2012 Apr; 103(1):32-7. PubMed ID: 22321201
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume histogram and dose-surface histogram analysis for skin reactions to carbon ion radiotherapy for bone and soft tissue sarcoma.
Yanagi T; Kamada T; Tsuji H; Imai R; Serizawa I; Tsujii H
Radiother Oncol; 2010 Apr; 95(1):60-5. PubMed ID: 19767117
[TBL] [Abstract][Full Text] [Related]
18. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
19. [Post-actinic retrobulbar optic neuropathy].
Borruat FX; Schatz NJ; Glaser JS
Klin Monbl Augenheilkd; 1996 May; 208(5):381-4. PubMed ID: 8766059
[TBL] [Abstract][Full Text] [Related]
20. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
